• 作者：Bá ; rbara Romero Guadix ; Luis Martí ; nez Navarro ; ^{luis.martinez.navarro.sspa@juntadeandalucia.es} ; Marí ; a Á ; ngeles Calderó ; n Rodrí ; guez ; Juan Fontes Jimé ; nez ; Rocí ; o Ló ; pez-Jurado Romero de la Cruz ; Marí ; a Setefilla Ló ; pez Criado
• 关键词：Sí ; ndrome de ovario poliquí ; stico ; Citrato de clomifeno ; Inseminació ; n artificial intrauterina
• 刊名：Progresos de Obstetricia y Ginecolog铆a
• 出版年：2009
• 期刊代码：pca294_03045013
• 类别：med
• 出版时间：February 2009
• 卷：52
• 期：2
• 页码：81-88
• 文件大小：100 K

Objective

To evaluate the results of ovulation induction cycles with gonadotropins and intrauterine insemination (IUI) carried out in women with polycystic ovary syndrome (POS) resistant to clomiphene citrate.

Material and methods

We performed an observational retrospective study of 462 ovulation induction cycles with IUI in women with SOP and clomiphene citrate resistance.

Results

The clinical pregnancy rate was 11.9%per cycle initiated and 14.74%per insemination and 45.45%of the pregnancies terminated in abortion. The effective accumulative percentage of term pregnancies per cycle initiated was 8%for the first cycle and 10.23%for insemination, increasing to 26.15%from the fifth cycle and to 32.24%from the fifth insemination. A total of 19.26%of the cycles was cancelled.

Conclusions

IUI is a useful method in women with SOP who are resistant to clomiphene citrate, with similar results to those obtained with other indications. These patients have high abortion and cycle cancellation rates. The high abortion rate should prompt research into ways of reducing reproductive loss.